Ovarian cancer trials in Australia

In Australia 59 Also abroad 803

59 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Where
Clayton, Melbourne, Nedlands
Age
18 years and over
People
460 worldwide
Run by
AstraZeneca
See details and how to joinNCT05123482 · EU 2022-502759-70-01
Phase 2Taking people
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Where
Adelaide, Auchenflower, Clayton, Geelong, Hobart, Kogarah, Melbourne, Richmond, Subiaco, Sydney
Age
18 years and over
People
400 worldwide
Run by
AbbVie
See details and how to joinNCT07059845 · EU 2025-521606-18-00
Phase 1Taking people
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Where
Blacktown, Clayton, Melbourne
Age
18 years and over
People
285 worldwide
Run by
AbbVie
See details and how to joinNCT07278336 · EU 2025-522209-40-00
Phase 1/2Taking people
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Where
East Melbourne
Age
18 years and over
People
120 worldwide
Run by
AstraZeneca
See details and how to joinNCT07115043
Phase 1Taking people
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Where
Camperdown, Heidelberg, Melbourne, Waratah
Age
18 years and over
People
473 worldwide
Run by
Bicara Therapeutics
See details and how to joinNCT04429542
Phase 1/2Taking people
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Where
Darlinghurst, Melbourne, Randwick
Age
18 years to 130 years
People
695 worldwide
Run by
AstraZeneca
See details and how to joinNCT05417594 · EU 2023-504984-17-00
Phase 1/2Taking people
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Where
Liverpool, Melbourne
Age
18 years to 130 years
People
622 worldwide
Run by
AstraZeneca
See details and how to joinNCT05797168 · EU 2022-502576-23-00
Phase 1/2Taking people
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Where
Bedford Park, Camperdown, Clayton, Nedlands, South Brisbane
Age
12 years and over
People
300 worldwide
Run by
PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750
Phase 3Taking people
A Study to Investigate Mocertatug Rezetecan With Bevacizumab Compared With Platinum Doublet With Bevacizumab in Participants With Platinum-sensitive Ovarian Cancer (BEHOLD-Ovarian02)
Where
Newcastle
Age
18 years and over
People
690 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07684612 · EU 2025-523366-24-00
Phase 1/2Taking people
Study of AVZO-021 in Patients With Advanced Solid Tumors
Where
Macquarie University, Wollongong
Age
18 years and over
People
430 worldwide
Run by
Avenzo Therapeutics, Inc.
See details and how to joinNCT05867251
Phase 1/2Completed
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Where
Melbourne, Randwick
Age
18 years and over
People
890 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT03564340 · EU 2024-510783-23-00
Phase 1/2Taking people
Evaluation of XYA02 in Patients With Advanced Solid Tumors
Where
Melbourne, Perth, Sydney
Age
18 years and over
People
190
Run by
XYone Therapeutics, Inc
See details and how to joinNCT07670312
Phase 1Taking people
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Where
Adelaide, Brisbane, Camperdown, Geelong, Sydney
Age
18 years and over
People
76 worldwide
Run by
Kivu Bioscience Inc.
See details and how to joinNCT07229313
Phase 2Taking people
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Where
Adelaide, Blacktown, Concord, Hobart
Age
18 years to 99 years
People
160 worldwide
Run by
Incyte Corporation
See details and how to joinNCT07023627 · EU 2025-521513-14-00
Phase 1/2Taking people
SL-28 for Advanced Solid Tumours
Where
Adelaide, Gold Coast, Sydney
Age
18 years and over
People
60
Run by
Second Life Therapeutics
See details and how to joinNCT07341737
Phase 3Taking people
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Where
Clayton, Hunter Regional Mail Centre, Parkville, Perth, Randwick, South Brisbane, Westmead
People
1,780 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT03067181
Phase 1Taking people
A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
Where
Southport, Waratah
Age
18 years to 75 years
People
299 worldwide
Run by
Huahui Health
See details and how to joinNCT07623369
Phase 1/2Taking people
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Where
Blacktown, Brisbane, Liverpool, Malvern, Melbourne, Nedlands
Age
18 years and over
People
1,109 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT04895709
Phase 1/2Taking people
A Study of DM002 in Patients With Advanced Solid Tumors
Where
Adelaide, Randwick, Wollongong
Age
18 years and over
People
280 worldwide
Run by
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
See details and how to joinNCT06751329
Phase 1Taking people
IDOV-Immune for Advanced Solid Tumors
Where
Melbourne, Westmead
Age
18 years and over
People
78 worldwide
Run by
ViroMissile, Inc.
See details and how to joinNCT06910657
Phase 2Taking people
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Where
Bedford Park, Melbourne, New Lambton Heights, Orange, Randwick
Age
8 years and over
People
254 worldwide
Run by
Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00
Phase 3Taking people
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
Where
Adelaide, Auchenflower, Campbelltown, Camperdown, Clayton, Cudgen, Garran, Gosford, Heidelberg, Kogarah, Melbourne, Richmond, St Leonards, Waratah
Age
18 years and over
People
1,100 worldwide
Run by
AstraZeneca
See details and how to joinNCT07218809 · EU 2025-520466-22-00
Phase 1Taking people
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
Where
Aberfoyle Park, South Brisbane
Age
18 years and over
People
100 worldwide
Run by
Stemline Therapeutics, Inc.
See details and how to joinNCT07226427 · EU 2025-524168-39-00
Phase 1Taking people
A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
Where
Adelaide, Ryde, Sydney, Westmead
Age
18 years and over
People
36
Run by
EtiraRx Australia Pty Ltd
See details and how to joinNCT06533332
Phase 2Taking people
A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
Where
Ballarat, Blacktown, Brisbane, Chermside, Clayton, Lambton Heights, Nedlands
Age
18 years and over
People
110 worldwide
Run by
AbbVie
See details and how to joinNCT06682988 · EU 2024-517184-23-00